Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fetal Hemoglobin

Known as: Hb F, Hemoglobin F, Fetal Hemoglobin [Chemical/Ingredient] 
The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult… Expand
National Institutes of Health

Related topics

Related topics

46 relations

Broader (2)

Fetal ProteinsHemoglobin

Narrower (36)

Hemoglobin F-AlbaicinHemoglobin F-Columbus-GaHemoglobin F-Forest ParkHemoglobin F-Hull
Expand
Hemoglobin F:PrThr:Pt:Bld:Ord:Alkali denatHemoglobin F:PrThr:Pt:Vomitus:OrdProcess of secretionSecond most predominant hemoglobin:Find:Pt:Bld.dot:Nom
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
Objective To determine whether there is a link between hypoglycaemia and mortality among participants in the Action to Control… Expand
Highly Cited
2010
Highly Cited
2010
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
BACKGROUND Results of intervention studies in patients with type 2 diabetes have led to concerns about the safety of aiming for… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Highly Cited
2009
Highly Cited
2009
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
BACKGROUND Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood… Expand
Highly Cited
2009
Highly Cited
2009
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in…
Aim  To compare the effects of combining liraglutide (0.6, 1.2 or 1.8 mg/day) or rosiglitazone 4 mg/day (all n ≥ 228) or placebo… Expand
Highly Cited
2008
Highly Cited
2008
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
BACKGROUND Exenatide is an incretin mimetic that shares glucoregulatory properties with glucagon-like peptide 1 (GLP-1), and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
2006
Review
2006
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis
Introduction and hypothesisDiabetes affects bone metabolism. The hypothesis was that type 1 (T1D) and type 2 (T2D) affects BMD… Expand
  • table 2
  • figure 1
  • table 4
  • table 5
Highly Cited
2002
Highly Cited
2002
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
BACKGROUND Glucagon-like peptide 1 (GLP-1) has been proposed as a treatment for type 2 diabetes. We have investigated the long… Expand
Review
2002
Review
2002
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention
Contents 
Review
2001
Review
2001
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
Abstract Objective: To examine the value of glycated haemoglobin (HbA1c) concentration, a marker of blood glucose concentration… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
1984
Highly Cited
1984
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
Hydroxyurea, a widely used cytotoxic/cytostatic agent that does not influence methylation of DNA bases, increases fetal… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE